These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 5880020)

  • 1. [Study on gastrointestinal permeability in ozena patients by means of I-131 polyvinylpyrrolidone].
    Bonaccorsi P; Badino G
    Boll Mal Orecch Gola Naso; 1965; 83(6):733-41. PubMed ID: 5880020
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gustatory sensitivity in ozena patients].
    Gotlib IaL; Khantemirov RG
    Zh Ushn Nos Gorl Bolezn; 1971; 31(6):73-5. PubMed ID: 5162079
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thyroid gland function in ozena patients].
    Vasil'ev VM
    Zh Ushn Nos Gorl Bolezn; 1970; 30(6):34-5. PubMed ID: 5521819
    [No Abstract]   [Full Text] [Related]  

  • 4. [Low-energy laser radiation in the combined therapy of ozena patients].
    Bikbaeva AI; Sharipov RA
    Vestn Otorinolaringol; 1986; (3):59-61. PubMed ID: 3727272
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thyroid function in ozenatous atrophic rhinitis].
    D'Amico P; Felletti V; Zibordi F
    Arch Ital Otol Rinol Laringol; 1966; 77(4):499-511. PubMed ID: 4382928
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in the vegetative nervous system in various chronic diseases of the nasal mucosa].
    Khromechek BI; Parilov VE; Shevchenko LB
    Vestn Otorinolaringol; 1983; (2):21-5. PubMed ID: 6857929
    [No Abstract]   [Full Text] [Related]  

  • 7. [Laser Doppler flowmetry for evaluation of nasal mucosa microcirculation].
    Liu D; Zhao Y; Zhou Y
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(6):366-7. PubMed ID: 7742031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of ozena and atrophic rhinitis with powder of sea kale].
    Loviankova ZN; Loseva VF; Shmel'kova LP
    Vestn Otorinolaringol; 1971; 34(1):95. PubMed ID: 5154289
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phagocytic activity of leukocytes in patients with ozena].
    Nesterenko EG; Svetlova ML
    Vestn Otorinolaringol; 1974; (3):86-8. PubMed ID: 4467411
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the etiology of systemic ozena].
    Zakrzewski J
    Otolaryngol Pol; 1993; 47(5):452-8. PubMed ID: 8259296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atrophic rhinitis and ozena].
    Mudrovici OR
    Rev Sanid Milit Argent; 1967; 66(2):137-45. PubMed ID: 5613551
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ozena. Surgical management].
    García Castañeda M
    Gac Med Mex; 1967 Jan; 97(1):44-5. PubMed ID: 5607462
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pathogenetic approach to the treatment of ozena].
    Rudenke VP
    Vestn Otorinolaringol; 1973; 35(1):18-21. PubMed ID: 4781541
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ozena and its surgical treatment. Late results of Lautenschläger's operation].
    Arndt HJ; Eggers TH
    HNO; 1966 Jul; 14(7):193-7. PubMed ID: 5998880
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of rhinopsychrometry in evaluating therapeutic results in ozena and scleroma].
    Gál P
    Cesk Otolaryngol; 1983 Jun; 32(3):152-4. PubMed ID: 6883529
    [No Abstract]   [Full Text] [Related]  

  • 16. [Possible correlations of ozena with some aspects of metabolism and homeostasis].
    Miloşescu P; Dragomirescu C; Panaiot G; Munteanu C; Cojocaru N
    Otorinolaringologie; 1965; 10(3):309-13. PubMed ID: 5862879
    [No Abstract]   [Full Text] [Related]  

  • 17. [Olfactory disorders in ozena].
    Rauh C; Mros B
    HNO; 1966 Jun; 14(6):179-80. PubMed ID: 5998392
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the occurrence and importance of Corynebacterium belfantii in ozena].
    Kewitsch A; Herrmann B; Herrmann H; Werner E
    Z Arztl Fortbild (Jena); 1971 Feb; 65(3):144-7. PubMed ID: 5575108
    [No Abstract]   [Full Text] [Related]  

  • 19. [The functional status of the gastrointestinal tract in patients with chronic relapsing urticaria].
    Suuklin GI; Smirnov VF
    Vestn Dermatol Venerol; 1967 Mar; 41(3):18-22. PubMed ID: 5603695
    [No Abstract]   [Full Text] [Related]  

  • 20. Gastro-intestinal toxicity related to bone marrow transplantation: disruption of the intestinal barrier precedes clinical findings.
    Johansson JE; Ekman T
    Bone Marrow Transplant; 1997 May; 19(9):921-5. PubMed ID: 9156267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.